Clinical Trial Update: Addressing Cognitive Fog in Long-COVID-19 Patients [Phase 4]

View source ↗

Summary

A Phase 4 trial evaluating cognitive fog in long-COVID-19 patients was terminated, with results posted on 2024-07-22.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Cognitive Impairment
• Long Covid

Snippet

Sponsor: Eva Szigethy | Conditions: Cognitive Impairment, Long COVID | Phase 4 | Status: TERMINATED | Results posted: 2024-07-22